Equity Research, Broker Reports, and media content on BIOCARTIS NV

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about BIOCARTIS NV
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on BIOCARTIS NV. We currently have 0 research reports from 0 professional analysts.

Date Source Announcement
22Dec16 06:01 GNW Biocartis Group NV: Biocartis and Amgen sign a RAS Biomarker Testing Collaboration in Europe
22Dec16 06:00 GNW Biocartis Group NV: Biocartis submits 510(k) file with US FDA for Idylla(TM) platform
15Dec16 06:00 GNW Biocartis Group NV: CE-marking Idylla(TM) NRAS-BRAF Mutation Test completes offering of metastatic colorectal cancer tests for clinical use on Idylla(TM) platform
14Dec16 06:00 GNW Biocartis Group NV: Disclosure of a transparency notification
12Dec16 06:00 GNW Biocartis Group NV: Disclosure of a transparency notification
07Dec16 06:00 GNW Biocartis Group NV: Biocartis launches second liquid biopsy assay - Assay co-developed with Merck for detection of KRAS mutations, operating directly on 1 ml blood plasma
28Nov16 06:00 GNW Biocartis Group NV: Disclosure of a transparency notification
  • Frequency of research reports

     

  • Research reports on

    BIOCARTIS NV

  • Providers covering

    BIOCARTIS NV